Body mass index as a factor influencing oocyte competence and implantation potential – distribution and results in 4,882 women undergoing fertility treatment

Authors

  • I. Antonova IVF department, Ob/Gyn “Dr Shterev Hospital” – Sofia, Bulgaria Author
  • D. Ivanov Department of Biology, Faculty of Pharmacy, Medical University „Prof. dr. Paraskev Stoyanov“ – Varna, Bulgaria Author
  • G. Yaneva Department of Biology, Faculty of Pharmacy, Medical University „Prof. dr. Paraskev Stoyanov“ – Varna, Bulgaria Author
  • N. Magunska Department of Health Care, Faculty of Public Health and Health Care, University of Ruse „Angel Kanchev“ – Ruse, Bulgaria Author
  • D. Duylgerova-Nikolova IVF department, Ob/Gyn “Dr Shterev Hospital” – Sofia, Bulgaria; IBIR – Bulgarian Academy of Science – Sofia, Bulgaria Author
  • M. Yunakova IVF department, Ob/Gyn “Dr Shterev Hospital” – Sofia, Bulgaria; Department of Obstetrics and Gynecology, Faculty of Medicine, Medical University – Sofia, Bulgaria Author
  • A. Shterev IVF department, Ob/Gyn “Dr Shterev Hospital” – Sofia, Bulgaria; Department of Health Care, Faculty of Public Health and Health Care, University of Ruse „Angel Kanchev“ – Ruse, Bulgaria Author

DOI:

https://doi.org/10.2478/AMB-2024-0013

Keywords:

BMI, obesity

Abstract

Introduction: The large amount of excess adipose tissue affects negatively every single step of the assisted reproductive treatment process – from the controlled ovarian hyperstimulation (COH) to obstetric complications and health consequences for the fetus. A number of scientific data show correlation between impaired clinical pregnancy rates (CPR) and obese patients maintaining high body 
mass index (BMI). The debate whether high proportion of body fat negatively affects oocyte quality or only impacts endometrial receptivity remains open. Aim: The aim of this study is to investigate the specific effect of the different BMI range in patients 
undergoing assisted reproductive technology (ART) treatment with reference to oocyte quality, fertilization capacity and implantation potential. Materials and methods: We analyzed a total of 4,882 women from partner couples who underwent ART treatment. Height and weight data were entered at the start of the in vitro fertilization (IVF) procedure. According to their BMI the female patients were divided in four distinct groups: in group 1 (underweight and BMI below 18.5 kg/m2) – 498 women, group 2 (normal range from 18.5 to 24.9 kg/m2) – 3021 women, group 3 (overweight with BMI between 25 – 29.9 kg/m2) – 789 women and group 4 (obese with BMI over 
30 kg/m2) – 484 women. Results: Distribution of the women in different BMI groups indicates that most of the Bulgarian patients undergoing fertility treatment are in the normal range. No association between BMI and ovarian response was found. A total 
of 33,205 oocytes were obtained after the COH. The mean numbers of the retrieved oocytes were similar (6,85 in group 1; 6,83 in group 2, 6,77 in group 3 and 6,67 in group 4) per woman and the fertilization rate was comparable in the four groups as it varies between 74-75%. Proportional categories of good, fair and bad embryos at cleavage stage were found. On the contrary, according to CPR, statistical difference between normal weight group (34,38%) versus overweight (29,6%) and obese groups (28,80%) (p < 0,05) was found. Conclusion: No correlation was found between the number of the retrieved oocytes and BMI values. Statistically lower pregnancy rates were reported in overweight women with BMI ≥ 25 kg/m² group and further onwards in the obesity group (BMI ≥ 30 kg/m²), which may be associated with impaired endometrial receptivity as a result of abnormally high levels of adipose tissue.

References

Organization WH. WHO European regional obesity report 2022: World Health Organization. Regional Office for Europe; 2022.

Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;143(21):e984-e1010.

Creanga AA, Catalano PM, Bateman BT. Obesity in pregnancy. New England Journal of Medicine. 2022; 387(3):248-59.

Kawwass JF, Kulkarni AD, Hipp HS, et al. Extremities of body mass index and their association with pregnancy outcomes in

women undergoing in vitro fertilization in the United States. Fertility and Sterility. 2016; 106(7):1742-50.

Sciorio R, Bellaminutti S, Tramontano L, et al. Impact of obesity on medically assisted reproductive treatments. Zygote. 2022; 30(4):431-9.

Gonzalez MB, Robker RL, Rose RD. Obesity and oocyte quality: significant implications for ART and emerging mechanistic insights. Biology of Reproduction. 2022; 106(2):338-50.

Snider AP, Wood JR. Obesity induces ovarian inflammation and reduces oocyte quality. Reproduction. 2019; 158(3):R79-R90.

Lainez NM, Coss D. Obesity, neuroinflammation, and reproductive function. Endocrinology. 2019; 160(11):2719-36.

Comstock IA, Diaz-Gimeno P, Cabanillas S, et al. Does an increased body mass index affect endometrial gene expression

patterns in infertile patients? A functional genomics analysis. Fertility and Sterility. 2017; 107(3):740-8.e2.

Shrestha D, La X, Feng HL. Comparison of different stimulation protocols used in vitro fertilization: a review. Annals of

translational medicine. 2015; 3(10).

Orvieto R. Triggering final follicular maturation-hCG, GnRHagonist or both, when and to whom? Journal of ovarian research. 2015; 8:1-6.

D’Angelo A, Panayotidis C, Amso N, et al. Recommendations for good practice in ultrasound: oocyte pick up. Human Reproduction Open. 2019;2019(4):hoz025.

Maggiulli R, Cimadomo D, Fabozzi G, et al. The effect of ICSIrelated procedural timings and operators on the outcome. Human Reproduction. 2020; 35(1):32-43.

Bridges PJ, Jeoung M, Kim H, et al. Methodology matters: IVF versus ICSI and embryonic gene expression. Reproductive biomedicine online. 2011; 23(2):234-44.

Berger DS, Hoff HS. Fertilization Assessment in IVF and ICSI. Principles of IVF Laboratory Practice: Laboratory Set-Up, Training and Daily Operation. 2023:207.

Medicine ASiR, Embryology ESIGo. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Human Reproduction. 2011; 26(6):1270-83.

Kermack AJ, Fesenko I, Christensen DR, et al. Incubator type affects human blastocyst formation and embryo metabolism:

a randomized controlled trial. Human Reproduction. 2022; 37(12):2757-67.

18. Glujovsky D, Retamar AMQ, Sedo CRA, et al. Cleavage-stage versus blastocyst-stage embryo transfer in assisted reproductive technology. Cochrane database of systematic reviews. 2022(5).

Clua E, Rodriguez I, Arroyo G, et al. Blastocyst versus cleavage embryo transfer improves cumulative live birth rates, time and cost in oocyte recipients: a randomized controlled trial. Reproductive BioMedicine Online. 2022; 44(6):995-1004.

Korkmaz C, Yıldız ÜG, Fidan U, et al. Investigation of transfer results of human embryos that were vitrified and thawed at the cleavage, morula and blastocyst stages. Zygote. 2020; 28(3):191-5.

Schiewe MC, Anderson RE. Vitrification: the pioneering past to current trends and perspectives of cryopreserving human embryos, gametes and reproductive tissue. Journal of Biorepository Science for Applied Medicine. 2017:57-68.

Nagy ZP, Shapiro D, Chang C-C. Vitrification of the human embryo: a more efficient and safer in vitro fertilization treatment. Fertility and sterility. 2020; 113(2):241-7.

Ojeda Varela M, Aguilar Prieto J, Táboas Lima E, et al. P-212 βhCG concentration in peripherical maternal blood after single embryo transfer, ongoing pregnancy rates and morphokinetics. Human Reproduction. 2023; 38(Supplement_1):dead093. 571.

Linh PK. Predictive value of βhCG measured on day 11 after blastocyst embryo transfer for early pregnancy outcome. Tạp chí Phụ sản. 2023;21(1):80-7.

Ouyang Y, Qin J, Lin G, et al. Reference intervals of gestational sac, yolk sac, embryonic length, embryonic heart rate at 6-10 weeks after in vitro fertilization-embryo transfer. BMC Pregnancy and Childbirth. 2020; 20(1):1-10.

Fedorcsák P, Storeng R, Dale PO, et al. Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta obstetricia et gynecologica Scandinavica. 2000; 79(1):43-8.

Sermondade N, Huberlant S, Bourhis-Lefebvre V, et al. Female obesity is negatively associated with live birth rate following IVF: a systematic review and meta-analysis. Human reproduction update. 2019; 25(4):439-51.

Rittenberg V, Seshadri S, Sunkara SK, et al. Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis. Reproductive biomedicine online. 2011; 23(4):421-39.

Lobstein T, Brinsden H, Neveux M. World obesity atlas 2022.

Mahase E. Obesity: No European country is on track to halt rising levels by 2025, WHO warns. BMJ: British Medical Journal (Online). 2022; 377:o1107.

Silvestris E, de Pergola G, Rosania R, et al. Obesity as disruptor of the female fertility. Reproductive Biology and Endocrinology. 2018; 16(1):22

Downloads

Published

27.06.2024

Issue

Section

ORIGINAL ARTICLES

How to Cite

Antonova, I., Ivanov, D., Yaneva, G., Magunska, N., Duylgerova-Nikolova, D., Yunakova, M., & Shterev, A. (2024). Body mass index as a factor influencing oocyte competence and implantation potential – distribution and results in 4,882 women undergoing fertility treatment. Acta Medica Bulgarica, 51(2), 8-13. https://doi.org/10.2478/AMB-2024-0013